Irene Konstantopoulou

Patriarchou Gregoriou E' & Neapoleos Street
Athens, ESYE31 15310, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal: Journal of medical genetics

Published: January 13, 2026

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers.

Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers.

Journal: Journal of the National Cancer Institute

Published: August 05, 2024

Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs.

Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs.

Journal: Oncology (Williston Park, N.Y.)

Published: July 18, 2024

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Journal: Cancers

Published: June 04, 2024

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.

Journal: medRxiv : the preprint server for health sciences

Published: March 18, 2024

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Journal: NPJ genomic medicine

Published: March 14, 2024

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 28, 2023

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

Journal: British journal of cancer

Published: November 07, 2022

Lung cancer as a predominant feature in a patient with Peutz-Jeghers syndrome: Case report.

Lung cancer as a predominant feature in a patient with Peutz-Jeghers syndrome: Case report.

Journal: Thoracic cancer

Published: January 30, 2022

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 25, 2022

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Journal: Communications biology

Published: November 15, 2021

Showing 1-12 of 86

Last Updated: 09/26/2026